Isolation and characterization of a small antiretroviral molecule affecting HIV-1 capsid morphology

Samir Abdurahman, Ákos Végvári, Micheal Levi, Stefan Höglund, Marita Högberg, Weimin Tong, Ivan Romero, Jan Balzarini, Anders Vahlne

Research output: Contribution to journalArticlepeer-review

6 Citations (SciVal)
158 Downloads (Pure)


Formation of an HIV-1 particle with a conical core structure is a prerequisite for the subsequent infectivity of the virus particle. We have previously described that glycineamide (G-NH2) when added to the culture medium of infected cells induces non-infectious HIV-1 particles with aberrant core structures.
Here we demonstrate that it is not G-NH2 itself but a metabolite thereof that affects HIV-1 infectivity and capsid assembly. The conversion of G-NH2 to its antiviral metabolite is catalyzed by an enzyme present in bovine and porcine but surprisingly not in human serum. Structure determination by NMR suggested that the active G-NH2 metabolite was α-hydroxyglycineamide (α-HGA). Chemically synthesized α-HGA inhibited HIV-1 replication to the same degree as G-NH2, unlike a number of other synthesized analogues of G-NH2 which had
no effect on HIV-1 replication. Comparisons by capillary electrophoresis and HPLC of the metabolite with the chemically synthesized α-HGA further confirmed that the antiviral GNH2-metabolite indeed was α-HGA.
α-HGA has an unusually simple structure and a novel mechanism of antiviral action. Thus, α-HGA could be a lead for new antiviral substances belonging to a new class of anti-HIV drugs, i.e. capsid assembly inhibitors.
Original languageEnglish
Issue number34
Publication statusPublished - 2009

Subject classification (UKÄ)

  • Medical Engineering


Dive into the research topics of 'Isolation and characterization of a small antiretroviral molecule affecting HIV-1 capsid morphology'. Together they form a unique fingerprint.

Cite this